16.03.2023 15:50 | XPP, FAN, STS | UK dividends calendar - next 7 days | Alliance |
16.03.2023 10:17 | HIK | Annual Financial Report and Notice of AGM | RNS |
13.03.2023 09:40 | FERG, BHP, ROO | LONDON BROKER RATINGS: JPMorgan cuts BAT; raises Bunzl | Alliance |
09.03.2023 09:15 | SRP, HIK, IWG | LONDON BROKER RATINGS: Liberum cuts National Express to 'sell' | Alliance |
06.03.2023 09:48 | NICL, CPI, ENQ | LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco | Alliance |
02.03.2023 09:30 | HIK | Total Voting Rights | RNS |
01.03.2023 09:52 | BOKU, RWS, RHIM | LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS | Alliance |
27.02.2023 09:26 | CRE, RSG, SNR | LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK | Alliance |
24.02.2023 09:37 | HIK, HWDN, SXS | LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith | Alliance |
23.02.2023 09:54 | HIK | Hikma Pharmaceuticals profit halves in 2022 on Generics impairment | Alliance |
23.02.2023 07:00 | HIK | Final Results | RNS |
17.02.2023 10:20 | HIK | Holding(s) in Company | RNS |
16.02.2023 15:49 | WPP, VRS, SXS | UK earnings, trading statements calendar - next 7 days | Alliance |
07.02.2023 09:36 | HIK | Notice of Results | RNS |
01.02.2023 10:18 | HIK | Total Voting Rights | RNS |
25.01.2023 09:33 | CRE, NICL, S32 | LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens | Alliance |
18.01.2023 10:16 | HIK | Director/PDMR Shareholding | RNS |
18.01.2023 09:39 | HIK | Holding(s) in Company | RNS |
17.01.2023 11:58 | HIK | Holding(s) in Company | RNS |
12.01.2023 17:55 | HIK, AREC | Arecor transfers AT307 drug to Hikma for development, regains AT282 | Alliance |
10.01.2023 15:42 | HIK | Additional Listing | RNS |
10.01.2023 09:20 | HIK | Director/PDMR Shareholding | RNS |
03.01.2023 09:25 | HIK | Hikma launches version of Xyrem medicine in US for treating narcolepsy | Alliance |
03.01.2023 09:24 | DRX, HIK, WIZZ | LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH | Alliance |
03.01.2023 09:23 | HIK | Total Voting Rights | RNS |
03.01.2023 07:00 | HIK | Hikma launches sodium oxybate in the US | RNS |
08.12.2022 09:48 | TTG, XPP, VLX | LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG | Alliance |
06.12.2022 10:26 | GNC, AIBG, BIRG | LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays | Alliance |
01.12.2022 09:24 | HIK | Total Voting Rights | RNS |
30.11.2022 07:00 | HIK | Hikma Injectables Portugal site visit | RNS |
22.11.2022 11:38 | HIK | Holding(s) in Company | RNS |
17.11.2022 09:50 | HIK | Holding(s) in Company | RNS |
15.11.2022 09:58 | AMS, RWI, ITM | LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform' | Alliance |
14.11.2022 09:25 | HTG, BIRG, SFOR | LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral' | Alliance |
08.11.2022 09:39 | AFM, ITM, WIZZ | LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson | Alliance |
03.11.2022 11:17 | HIK | Hikma Pharmaceuticals reiterates 2022 guidance as costs widen | Alliance |
03.11.2022 07:00 | HIK | Trading Statement | RNS |
13.10.2022 15:00 | HIK | Directorate Change | RNS |
05.10.2022 12:16 | HIK | Holding(s) in Company | RNS |
04.10.2022 10:05 | HIK | Holding(s) in Company | RNS |
04.10.2022 09:24 | 888, AJB, DNLM | LONDON BROKER RATINGS: Upgrades for Vodafone, AJ Bell, B&M, Pennon | Alliance |
03.10.2022 15:52 | HIK | Block listing Interim Review | RNS |
03.10.2022 15:11 | HIK | Total Voting Rights | RNS |
30.09.2022 11:08 | NETW, AWE, IQE | IN BRIEF: Hikma addresses gender imbalance with two new non-executives | Alliance |
30.09.2022 07:00 | HIK | Director changes and update on AGM 2022 resolution | RNS |
15.09.2022 09:30 | FEVR, JSG, ITM | LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK | Alliance |
14.09.2022 09:19 | HIK | Change of Hikma interim dividend payment date | RNS |
12.09.2022 15:55 | QLT, PSON, IPO | UK dividends calendar - next 7 days | Alliance |
01.09.2022 14:25 | HIK | Total Voting Rights | RNS |
31.08.2022 20:31 | XPP, TYMN, GNC | TOP NEWS: ConvaTec to join FTSE 100 as abrdn vacates spot | Alliance |
30.08.2022 13:59 | HIK | Hikma Pharmaceuticals launches allergy nasal spray Ryaltris in US | Alliance |
30.08.2022 12:22 | HIK | Hikma launches RYALTRIS | RNS |
23.08.2022 15:12 | HIK | Director/PDMR Shareholding | RNS |
11.08.2022 15:40 | GSEO, UKCM, TIFS | UK dividends calendar - next 7 days | Alliance |
05.08.2022 10:02 | BIRG, JET, DLG | LONDON BROKER RATINGS: Jefferies cuts Go-Ahead, Mediclinic to 'hold' | Alliance |
05.08.2022 08:15 | LSEG, CTEC, NXT | LONDON BRIEFING: London Stock Exchange benefits from market volatility | Alliance |
04.08.2022 09:00 | HIK | TOP NEWS: Hikma first half hit by stiff competition for Generics | Alliance |
04.08.2022 07:00 | HIK | Half-year Report | RNS |
01.08.2022 16:48 | HIK | Total Voting Rights | RNS |
28.07.2022 16:06 | BBOX, SPT, SRP | UK earnings, trading statements calendar - next 7 days | Alliance |
18.07.2022 09:46 | SBRE, FEVR, AML | LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut | Alliance |
18.07.2022 09:26 | HIK | Notice of Results | RNS |
13.07.2022 10:02 | BRK, HTG, ENQ | LONDON BROKER RATINGS: Jefferies likes Tyman; UBS cuts Beazley | Alliance |
01.07.2022 10:52 | HIK | Total Voting Rights | RNS |
15.06.2022 15:00 | HIK | Company Secretary Change | RNS |
15.06.2022 13:46 | HIK | Director/PDMR Shareholding | RNS |
10.06.2022 18:08 | HIK | Transaction in Own Shares | RNS |
09.06.2022 17:14 | HIK | Transaction in Own Shares | RNS |
08.06.2022 17:15 | HIK | Transaction in Own Shares | RNS |
07.06.2022 17:13 | HIK | Transaction in Own Shares | RNS |
06.06.2022 17:14 | HIK | Transaction in Own Shares | RNS |
01.06.2022 18:08 | HIK | Transaction in Own Shares | RNS |
31.05.2022 17:52 | HIK | Transaction in Own Shares | RNS |
31.05.2022 10:00 | HIK | Director/PDMR Shareholding | RNS |
30.05.2022 17:23 | HIK | Transaction in Own Shares | RNS |